Pages that link to "Q33980633"

The following pages link to Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type (Q33980633):

Displaying 30 items.

• The RSV fusion receptor: not what everyone expected it to be (Q28272863) (← links)
• RSV fusion: time for a new model (Q28287657) (← links)
• Roles of nucleolin. Focus on cancer and anti-cancer therapy (Q34047719) (← links)
• A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis (Q34221688) (← links)
• Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L (Q34475097) (← links)
• Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery (Q35672973) (← links)
• Human anti-nucleolin recombinant immunoagent for cancer therapy (Q35690196) (← links)
• Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis (Q36140779) (← links)
• Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration. (Q36508636) (← links)
• Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model. (Q36561693) (← links)
• Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. (Q36907845) (← links)
• Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging (Q37256221) (← links)
• Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands (Q37698301) (← links)
• Involvement of nuclear protein C23 in activation of EGFR signaling in cervical cancer (Q38845264) (← links)
• The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas (Q38915468) (← links)
• Identification of cellular proteins that interact with Newcastle Disease Virus and human Respiratory Syncytial Virus by a two-dimensional virus overlay protein binding assay (VOPBA). (Q38967386) (← links)
• Nucleolin promotes TGF-β signaling initiation via TGF-β receptor I in glioblastoma (Q39010093) (← links)
• Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-α-inducing protein of Helicobacter pylori (Q39061507) (← links)
• The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis (Q39232685) (← links)
• Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release. (Q39251761) (← links)
• Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. (Q39368829) (← links)
• Synthesis and evaluation of an (18) F-labeled derivative of F3 for targeting surface-expressed nucleolin in cancer and tumor endothelial cells. (Q41593876) (← links)
• Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer (Q44428129) (← links)
• Targeted therapy of human glioblastoma via delivery of a toxin through a peptide directed to cell surface nucleolin. (Q47755537) (← links)
• Glycosilated nucleolin as marker for human gliomas. (Q48883976) (← links)
• Targeting nucleolin for better survival in diffuse large B-cell lymphoma. (Q52583133) (← links)
• The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. (Q54077957) (← links)
• Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies. (Q54988217) (← links)
• Targeting surface nucleolin induces autophagy-dependent cell death in pancreatic cancer via AMPK activation (Q57793872) (← links)
• Host and Viral Factors in Respiratory Syncytial Virus Infection (Q90747138) (← links)